Navigation Links
New Fertility Treatment Option Now Available for Cancer Patients
Date:8/12/2009

Montefiore's Institute for Reproductive Medicine & Health Only Site in New York Metro Area to Offer This Breakthrough Procedure

HARTSDALE, N.Y., Aug. 12 /PRNewswire-USNewswire/ -- Cancer patients who want to start a family in the future now have a new option. Montefiore's Institute for Reproductive Medicine & Health is the only site in the New York metropolitan area and one of approximately 25 sites across the country to offer a new treatment option to preserve fertility for female patients undergoing cancer treatment. Offered in collaboration with The Oncofertility Consortium at Northwestern University, this procedure, called Ovarian Tissue Cryopreservation, removes one ovary and freezes the ovarian tissue before the woman begins undergoing chemotherapy. Twenty percent of the tissue is used for research and 80 percent will be held for the patient for use when she is ready to have a baby.

"We are pleased to now offer this promising new option for cancer patients who may want to conceive at a future time," said Edward Illions, M.D., who is the lead physician for the program.

This procedure, which is currently available for women of childbearing age from 18-42, is being offered as a possible choice for those who have to begin chemotherapy immediately because of the nature of their cancer diagnosis. It involves removing a section of ovarian tissue containing eggs, freezing them and then thawing them at a later date. Additional research will concentrate on techniques to isolate and grow immature follicles in the lab setting (called in vitro follicle maturation). Once matured, the eggs within these follicles can be fertilized to create embryos as in traditional In Vitro Fertilization (IVF).

This procedure is a promising alternative to IVF, freezing embryos and freezing eggs - processes that require as much as three to
'/>"/>

SOURCE Montefiore Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Fertility Can Be Preserved in Ovarian Cancer Patients
2. Young early stage ovarian cancer patients can preserve fertility
3. Unlocking the key to human fertility
4. FREE INFERTILITY SEMINAR: Fertility Options 101
5. Male Fertility Supplement Improves Sperm Quality & Motility in Clinical Study
6. Studies shed light on preserving fertility among cancer patients
7. New e.p.t.(R)/BabyCenter(R) Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In-Vitro Fertilization
8. FertilityAuthority Introduces E-Newsletter, The Daily Shot
9. New Fertility Financing for Donated Eggs Fills Void Left by Capital One
10. New technique could sustain cancer patients fertility
11. New technique could save cancer patients fertility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... time? How can women meet the demands of a ... become a mother has a profound effect on the ... the physical sciences. Yet many women successfully manage to ... Professor, fifteen inspirational personal accounts describe the challenges and ... chemistry. , The authors of the contributions are all ...
(Date:7/22/2014)... much-studied thing. Scientists have analyzed its blood flow, rhythms, ... heart. But for the first time, researchers are looking ... conditions of space flight affect those hearts for up ... Space Station. Lessons learned may help improve cardiovascular health ... imbalance in the body,s ability to handle toxic byproducts ...
(Date:7/22/2014)... The European Bio stimulants Market report defines ... analysis and forecast of revenue. The bio stimulants market ... million in 2013 to $940.6 million by 2018, at ... Browse through the TOC of the Europe Bio stimulants ... analysis provided. , http://www.micromarketmonitor.com/market/europe-bio-stimulants-1315565884.html , Agriculture contributes ...
(Date:7/22/2014)... 22, 2014 Alliance Storage ... data archiving solutions, has announced the availability of ... archiving solution. The unique new solution merges optical ... on compliant data archiving across all industries including ... The introduction of the new archiving tier permits ...
(Date:7/22/2014)... from the University of Murcia have studied the ... impulsiveness, a personality trait that causes difficulties in ... stimulus and leads to unplanned actions without considering ... an indicator for predicting the risk of behavioural ... from the University of Murcia analyses whether the ...
Breaking Medicine News(10 mins):Health News:The heart of an astronaut, five years on 2Health News:The heart of an astronaut, five years on 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Data Archiving Leader Alliance Storage Technologies Releases Enterprise Class Cloud-Integrated Storage Solution 2Health News:Data Archiving Leader Alliance Storage Technologies Releases Enterprise Class Cloud-Integrated Storage Solution 3Health News:Data Archiving Leader Alliance Storage Technologies Releases Enterprise Class Cloud-Integrated Storage Solution 4Health News:Children's impulsive behaviour is related to their brain connectivity 2
... They Don,t Fully Understand the Details ... of Their Health Insurance Plan, WESTLAKE ... insurers across the U.S., yet,contacting plan members regularly and increasing their ... ratings,more renewal business and additional sales of services to members,according to ...
... in the cross hairs of radiation or chemotherapy may ... are jammed, say University of Florida scientists writing in ... fruit fly cells discovered that slight changes in the ... aptly named for their roles in triggering cell ...
... American Heart,Association presented six Awards of Meritorious Achievement yesterday at,its ... Washington, D.C.,The award recognizes individuals for specific, significant accomplishments,or projects ... -- Kenneth M. Baker, M.D., professor and vice-chair ... of Medicine at the Texas A&M Health Science Center in ...
... toward Clinical Testing of Stem Cells Developed from Patients, ... ... April 30 Researchers have succeeded in,inducing stem cells grown from ... to a study publishing,online tomorrow in the journal "Stem Cells.", ...
... the key cells involved in both the synthesis and ... the plant extract Cpd 861 can regulate the expression ... an antifibrotic effect. , This research, performed by Dr. ... Institute, was published on March 21, 2008, in the ...
... TUSTIN, Calif., April 30 AMDL, Inc. ... in Shenzhen,Jiangxi, and Jilin, China, is a ... its subsidiary Jade,Pharmaceutical Inc., (JPI), the Company ... of diagnostic, pharmaceutical,nutritional supplement, and cosmetic products., ...
Cached Medicine News:Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 2Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 3Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 4Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 5Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 6Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 7Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 8Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 9Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 10Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 11Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 12Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 13Health News:'Destruct' triggers may be jammed in tumor cells, UF geneticists say 2Health News:Six Receive Association's Award of Meritorious Achievement 2Health News:Mouse Adult Stem Cells Developed into Heart and Blood Cells 2Health News:Mouse Adult Stem Cells Developed into Heart and Blood Cells 3Health News:New findings: The anti-fibrotic mechanism of plant extract Cpd 861 2Health News:AMDL Signs MOU for 200 Store Distribution Arrangements for Goodnak Product Line 2
(Date:7/22/2014)... Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and ... lots of Fluzone ® (Influenza Vaccine) for the 2014-2015 ... Food and Drug Administration (FDA) for distribution. The lots were ... least 65 million doses of seasonal influenza vaccine manufactured by ... providers and pharmacies in August. The U.S. ...
(Date:7/22/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today ... patients in its ongoing Phase 2 trial (Study 202) ... revised clinical protocol agreed to with the FDA in ... proprietary recombinant human hyaluronidase under development for the systemic ... "Our diligent effort to rapidly re-initiate patient enrollment and ...
(Date:7/22/2014)... 22, 2014 The Intellectual ... , the world,s leading provider of intelligent ... Cortellis Clinical Trials Intelligence , its ... milestone with the documentation of more than ... with greater and quicker access to critical ...
Breaking Medicine Technology:Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3
...  InterMune, Inc. (NADSAQ: ITMN) today reported that ... its decision granting the additional benefit of ... of mild-to-moderate idiopathic pulmonary fibrosis (IPF).  Esbriet,s ... (not quantifiable benefit)  in the rating system ...
... Pharma Holdings, Inc. (NYSE AMEX: CPHI ) ("China ... China, today announced financial results for the year ended December ... , Revenue increased 9% to $81.2 million in fiscal ... , Income from operations was $22.0 million in fiscal year ...
Cached Medicine Technology:Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 2Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 3Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 4Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 5Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 6China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 2China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 3China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 4China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 5China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 6China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 7China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 8China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 9China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 10China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 11China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 12
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: